Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 1
2015 1
2016 3
2017 1
2018 8
2019 4
2020 9
2021 16
2022 11
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations.
Burgard C, Rosar F, Marlowe RJ, Bartholomä M, Dewes S, Schaefer-Schuler A, Linxweiler J, Khreish F, Ezziddin S. Burgard C, et al. Among authors: linxweiler j. Cancers (Basel). 2023 May 3;15(9):2592. doi: 10.3390/cancers15092592. Cancers (Basel). 2023. PMID: 37174058 Free PMC article.
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.
Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, Neuberger M, Worst TS, von Hardenberg J, Linxweiler J, Klümper N. Wenzel M, et al. Among authors: linxweiler j. Urol Oncol. 2022 Dec;40(12):538.e7-538.e14. doi: 10.1016/j.urolonc.2022.09.011. Epub 2022 Oct 14. Urol Oncol. 2022. PMID: 36244915
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [177Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience.
Rosar F, Bader H, Bartholomä M, Maus S, Burgard C, Linxweiler J, Khreish F, Ezziddin S. Rosar F, et al. Among authors: linxweiler j. Cancers (Basel). 2022 May 29;14(11):2691. doi: 10.3390/cancers14112691. Cancers (Basel). 2022. PMID: 35681671 Free PMC article.
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC.
Rosar F, Neher R, Burgard C, Linxweiler J, Schreckenberger M, Hoffmann MA, Bartholomä M, Khreish F, Ezziddin S. Rosar F, et al. Among authors: linxweiler j. Cancers (Basel). 2022 Mar 26;14(7):1696. doi: 10.3390/cancers14071696. Cancers (Basel). 2022. PMID: 35406467 Free PMC article.
54 results